The state of the art of cancer control in 30 European countries in 2008

Int J Cancer. 2010 Jun 1;126(11):2700-15. doi: 10.1002/ijc.24963.

Abstract

Inequalities in cancer incidence, mortality and survival represent a major challenge for public health. Addressing this challenge requires complex and multidisciplinary approaches. Sharing successful experiences from across Europe may therefore be of benefit. We describe the state of the art of cancer control structures in the 27 European Union countries, plus Iceland, Norway and Switzerland, at the beginning of 2008. Information on cancer plans, cancer registries, cancer screening, Human Papillomavirus (HPV) vaccination and smoking restrictions in each country was identified through PubMed, the official websites of national and international organizations and Google searches. Experts and/or health authorities from each country completed and validated the information. Sixteen countries had implemented national cancer plans in 2008. Twenty four countries had population-based cancer registries with 100% coverage. The exceptions were Greece and Luxembourg (no population-based registry yet), France, Italy and Spain (<50%), and Switzerland (62%). In 9 countries, population coverage of breast cancer screening was 100% with participation ranging from 26 to 87%; 8 countries did not have organized programmes. Seven countries had cervical cancer screening programmes with 100% coverage with participation ranging from 10 to 80%; 8 countries had no organized programme. Nine countries had announced national HPV vaccination policies by early 2008. Six countries had organized colorectal cancer screening programmes. Five countries had complete bans on smoking in public places. There is wide international heterogeneity in cancer control structures in Europe. This provides considerable scope and motivation for cooperation and sharing of experience.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Europe / epidemiology
  • European Union / statistics & numerical data
  • Humans
  • Incidence
  • Internet
  • Mass Screening / methods
  • Mass Screening / organization & administration
  • Neoplasms / epidemiology*
  • Neoplasms / mortality
  • Neoplasms / prevention & control*
  • Papillomavirus Vaccines / therapeutic use
  • Public Health / standards
  • Registries
  • Smoking Cessation / statistics & numerical data
  • Survival Rate

Substances

  • Papillomavirus Vaccines